Omixon Email Format
Biotechnology ResearchBudapest, Hungary51-200 Employees
Omixon is a biotechnology company focused on transplantation diagnostics, delivering tools to histocompatibility laboratories to improve transplant outcomes. Based in Budapest, Hungary, with operations in the United States, Brazil, and the Netherlands, it serves more than 100 laboratories worldwide. The company combines expertise in bioinformatics, software engineering, molecular biology, and regulatory science to translate molecular biology innovations into diagnostic products. In 2014, Omixon introduced a sequencing-based HLA typing kit and accompanying software, establishing itself in high-resolution genotyping. It has expanded its offerings to include rapid high-resolution HLA typing using long-read sequencing and a donor-derived cell-free DNA kit designed for labs with donor-informative markers. In October 2024, Werfen announced the completion of its acquisition of Omixon.